News

News

Release

Abolis Biotechnologies secures 35 Mio. Euro

Abolis Biotechnologies secures 35 Mio. Euro from International Consortium of Industrials and Funds

Company

Magazine ELEMENTS

We are dedicated to pioneering sustainable and innovative solutions for the beauty and personal care industry. We are thrilled to highlight our partnership with Abolis, which enhances our commitment to leveraging biotechnology in our formulations.

Events

BIO International Convention 2025

Abolis, a proud member of @Genopole, is excited to join the Business France delegation at BIO International Convention 2025! We will be showcasing cutting-edge microbial biotechnology and our Microbiome Studio solutions.

Abolis Biotechnologies